CTOs on the Move

Concert Pharmaceuticals

www.concertpharma.com

 
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company`s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Funding

Concert Pharmaceuticals raised $30M on 06/12/2017
Concert Pharmaceuticals raised $66.4M on 06/01/2022

Similar Companies

TABUK Pharmaceuticals

TABUK Pharmaceuticals is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phagetech

Phagetech is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

harris pharmaceutical

harris pharmaceutical is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viatris

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.

Prism Health North Texas

PHNTX is the largest local nonprofit HIV/AIDS service organization in North Texas providing HIV care, free STI and HIV testing, transgender care, and more.